Cargando…

The role of B cells in systemic sclerosis

Systemic sclerosis (SSc) is a connective disease characterized by features of autoimmunity, vasculopathy, inflammation, and fibrosis. The disease typically starts with Raynaud’s phenomenon, followed by skin thickening in the extremities due to inflammation and fibrosis. Fibrosis results from excessi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kraaij, Marina D, van Laar, Jacob M
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721390/ https://www.ncbi.nlm.nih.gov/pubmed/19707370

Ejemplares similares

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
por: van Laar, Jacob M
Publicado: (2010)

The immunopathology of systemic sclerosis
por: van Laar, Jacob M., et al.
Publicado: (2015)

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020)

Interleukin-6: a new therapeutic target in systemic sclerosis?
por: O'Reilly, Steven, et al.
Publicado: (2013)

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

Cellular Therapies in Systemic Sclerosis: Recent Progress
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2016)

Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis
por: Binai, Nadine, et al.
Publicado: (2012)

Dual Role of B Cells in Multiple Sclerosis
por: Kumar, Gaurav, et al.
Publicado: (2023)

Role of B-Cell in the Pathogenesis of Systemic Sclerosis
por: Thoreau, Benjamin, et al.
Publicado: (2022)

Immune ablation and stem-cell therapy in autoimmune disease: Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation
por: van Laar, Jacob M
Publicado: (2000)

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis
por: Spierings, Julia, et al.
Publicado: (2021)

Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
por: Spierings, Julia, et al.
Publicado: (2021)

The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis
por: Spasovski, Vesna, et al.
Publicado: (2023)

Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
por: Chiu, Yu-Hsiang, et al.
Publicado: (2023)

Stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2008)

Role of Alarmins in the Pathogenesis of Systemic Sclerosis
por: Giovannetti, Antonello, et al.
Publicado: (2020)

Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis
por: Wootla, Bharath, et al.
Publicado: (2011)

Treatment of systemic sclerosis: potential role for stem cell transplantation
por: Xiong, Wen, et al.
Publicado: (2009)

The Role of BDNF in Multiple Sclerosis Neuroinflammation
por: Nociti, Viviana, et al.
Publicado: (2023)

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
por: Ciechomska, Marzena, et al.
Publicado: (2013)

Allogeneic stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2010)

Emerging Roles of Matricellular Proteins in Systemic Sclerosis
por: Feng, Daniel, et al.
Publicado: (2020)

Role of NLRP3 inflammasome in systemic sclerosis
por: Lin, Cong, et al.
Publicado: (2022)

The Role of PPAR Gamma in Systemic Sclerosis
por: Dantas, Andréa Tavares, et al.
Publicado: (2015)

The Role of CCL24 in Systemic Sclerosis
por: Levy, Hilit, et al.
Publicado: (2023)

Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis
por: Silva, Inês S., et al.
Publicado: (2023)

Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis
por: Schouffoer, Anne A., et al.
Publicado: (2011)

B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung Disease
por: Bounia, Constantina A., et al.
Publicado: (2022)

B Cells and Autoantibodies in Multiple Sclerosis
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Impact of B cells to the pathophysiology of multiple sclerosis
por: Arneth, Borros M.
Publicado: (2019)

Cell therapy for autoimmune diseases
por: Dazzi, Francesco, et al.
Publicado: (2007)

Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function
por: Lehmann-Horn, Klaus, et al.
Publicado: (2017)

How does endothelial cell injury start? The role of endothelin in systemic sclerosis
por: Abraham, David, et al.
Publicado: (2007)

Cortical injury in multiple sclerosis; the role of the immune system
por: Walker, Caroline A, et al.
Publicado: (2011)

The role of regional and neuroaxial anesthesia in patients with systemic sclerosis
por: Dempsey, Zoey Sarah, et al.
Publicado: (2011)

The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
por: Kanno, Yosuke
Publicado: (2019)

The role of adipokines in systemic sclerosis: a missing link?
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
por: Vonk, Madelon C
Publicado: (2020)

The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis
por: Lee, Michael H, et al.
Publicado: (2019)

The role of information system in multiple sclerosis management
por: Ajami, Sima, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mkob5l6da48ga88d3bcn5u6tl7